Corbus Pharmaceuticals Announces Appointment of Craig Millian as Chief Commercial Officer
March 04, 2019 09:15 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Advances commercialization strategy for lenabasum ahead of data readouts of key registrational studies in 2020, and potential U.S. Food and Drug Administration (“FDA”) approval and launch in 2021Mr....